以下部分引用 AI 总结，现阶段 AI 仍然有幻觉。请以内容的原文为准。

数据新鲜度群聊 07-14 ✓卖方 07-14 ✓Wrap 断档15天 ✕News 07-15 ✓X 断档12天 ✕页面生成 07-15

FDA

44 atoms · 跨 22 天 · 首见 2026-04-15 · 最近 2026-06-30

三色: 🟦 fact 39 · 🟥 take 5 · stance ▲3/▼5/◆22

叙事状态: 🍂 fading (退潮) · 💤 沉寂 · 策展近14d 0 atom · 🐦 X 近14d 3

状态只算低频策展源 (群/卖方); X firehose 仅作背景音量

来源: X 44

时态: fresh:43 · aging:1

标签: 好信源:33 · 好数字:7 · 好观点:6 · 好思考:1 · 好问题:1

🟨 AI 综合 · junior analyst 概览

展开 AI 综合 (灰色 · 非市场结论 · 点击数字溯源到原 atom)

model: deepseek-chat · 2026-07-12 · 默认折叠

FDA领导层正经历变动，前局长Marty Makary离任后，代理局长透露后Makary时代将有重大改革 [id=a60cff00348e8a7a][id=b9a5dc32d90d04c5]。监管态势呈现显著分歧：一方面，FDA对亨廷顿病药物AMT-130的BLA路径给出积极反馈 [id=a4368ee7557de532]，有观点认为若拒绝该候选药将是荒谬之举 [id=4791ae88f5b9bc2e]；另一方面，FDA对多肽行业提出重大挫折——建议不将7种多肽列入503A散装清单 [id=5133738a8088d4d1][id=cb1a36f42a96d062]，并因对AMT-130研究数据的不理性处理，削弱了相关平台的可信度 [id=e1553bbbe0ccb7ce]。此外，FDA近期批准了防晒霜新成分BEMT [id=d585794aab1f08dc]，但其历史中曾禁女性参与临床试验长达16年（1977-1993），导致多数“女性用药”仍在男性身上测试 [id=06a829ccbc0b870a][id=745ef6455d56176b]。

🧭 拥挤度 (一人一票): ▲ 2 位作者 (KOL2) vs ▼ 2 位作者 (KOL2)

📄 广泛报道的事实 · 1 个

展开 (多人转述同一事实/数字 — 确认度高, **非独立观点**, 不标多空)

建议反对添加7种肽类药物至503A Bulk List — 2 源报道 (含1快讯) · X

💢 核心分歧 (1 轴)

1. AI 加速审批效率提升 vs 安全风险

*topic: 监管政策 · 3 bull vs 5 bear*

🟢 bullish 侧:

<a id="atom-5e3bb39a051abb8e"></a>2026-04-28 X·@wallstengine · 试点AI目标 · 监管政策
The goal is to speed up trials, get drugs to patients faster, and boost U.S. biotech.
tags: 好信源 · → daily
📷 原图
<a id="atom-4791ae88f5b9bc2e"></a>2026-05-22 X·@MoodyWriter13 · 候选药物审批决策 · 监管政策
The FDA must be crazy not to approve their candidate for Huntington's disease
tags: 好观点 · → daily
value: date=next 1-2 years
<a id="atom-a4368ee7557de532"></a>2026-06-17 X·@AIStockSavvy · 对AMT-130的BLA路径反馈 · 监管政策
FDA's positive feedback on the BLA pathway for AMT-130 in Huntington's as a major positive
tags: 好信源 · → daily
value: direction=positive
📷 原图

🔴 bearish 侧:

<a id="atom-99323541f0da382c"></a>2026-04-27 X·@FirstSquawk · proposed pulling approval for · 监管政策
The FDA’s Center for Drug Evaluation and Research (CDER) has proposed pulling approval for Tavneos.
tags: 好信源 · → daily
value: qty=Tavneos
<a id="atom-745ef6455d56176b"></a>2026-05-19 X·@bryan_johnson · 禁止女性参与临床试验 · 监管政策
most 'medicine for women' is still medicine tested in men
tags: 好数字 · → daily
value: duration=1977 to 1993
📷 原图
<a id="atom-e1553bbbe0ccb7ce"></a>2026-06-17 X·@MoodyWriter13 · 对AMT-130研究数据的不理性处理 · 监管政策
The old FDA, through its irrational handling of the AMT-130 study data from $QURE , essentially delegitimized the platform of $CLPT.
tags: 好观点 · → daily
<a id="atom-d8e0337780c07e26"></a>2026-06-30 X·@tbpn · 建议不将7种多肽列入503A散装清单 · 监管政策 +同日1条
FDA staff recommends against adding all 7 peptides under review to the 503A Bulks List.
tags: 好信源 · → daily

展开 18 条中性

<a id="atom-cbdfea169ca1f08c"></a>2026-04-15 X·@wallstengine [老化中] · 将许多肽类从类别二移除 · 监管政策
RFK JR: FDA TO REMOVE MANY PEPTIDES FROM CATEGORY TWO
tags: 好信源 · → daily
value: qty=移除 · date=2026-04-15
<a id="atom-3b67b001db06bda2"></a>2026-04-15 X·@AIStockSavvy · 设置AdCom会议 · 监管政策
FDA sets up AdCom meeting to decide on lifting restrictions on certain peptides
tags: 好信源 · → daily
value: qty= · date=
<a id="atom-2b49e10a9b13cf4d"></a>2026-04-16 X·@AIStockSavvy · 信号鼓励睾丸素疗法新适应症 · 监管政策
FDA encourages new indication for testosterone therapy in low libido.
tags: 好信源 · → daily
value: qty=低性欲 · date=2026-04-16
<a id="atom-a5188d636bc66633"></a>2026-04-28 X·@FirstSquawk · leveraging AI to accelerate clinical trials · 监管政策
THE FDA LEVERAGES ARTIFICIAL INTELLIGENCE TO ACCELERATE CLINICAL TRIALS — WSJ.
tags: 好信源 · → daily
<a id="atom-a465d912a20d4070"></a>2026-04-28 X·@wallstengine · 计划今年夏天试点AI · 监管政策
The FDA plans to pilot AI this summer to pull clinical trial data directly from electronic health records and send it in real time to drugmakers and regulators.
tags: 好信源 · → daily
value: date=2026年夏天
📷 原图

🟦 客观事实 (facts) (16)

<a id="atom-b9a5dc32d90d04c5"></a>🟦 2026-06-04 X·@ZacharyBrennan ⭐ · 领导层变动计划 · 监管政策/人事变动
acting FDA commissioner Kyle Diamantas told rare disease nonprofits yesterday that some major changes are coming in the post-Makary era
tags: 好思考·好信源·好观点 · → daily
value: date=post-Makary era
<a id="atom-cb1a36f42a96d062"></a>🟦 2026-06-29 X·@RxRegA · 建议反对添加7种肽类药物至503A Bulk List · 监管政策
FDA staff recommends against adding all 7 peptides under review to the 503A Bulks List.
tags: 好信源·好问题 · → daily
<a id="atom-06a829ccbc0b870a"></a>🟦 2026-05-19 X·@bryan_johnson · 禁止女性参与临床试验年限 · 监管政策
The FDA banned women from clinical trials for 16 years (1977 to 1993)
tags: 好数字 · → daily
value: duration=1977 to 1993
📷 原图
<a id="atom-745ef6455d56176b"></a>🟦 2026-05-19 X·@bryan_johnson · 禁止女性参与临床试验 · 监管政策
most 'medicine for women' is still medicine tested in men
tags: 好数字 · → daily
value: duration=1977 to 1993
📷 原图
<a id="atom-d8e0337780c07e26"></a>🟦 2026-06-30 X·@tbpn · 建议不将7种多肽列入503A散装清单 · 监管政策
FDA staff recommends against adding all 7 peptides under review to the 503A Bulks List.
tags: 好信源 · → daily
<a id="atom-2f28bb8b69a5af38"></a>🟦 2026-06-25 X·@levchizhov · 微泡批准状态 · 监管政策
They're FDA-approved and live for 1-2 minutes.
tags: 好信源 · → daily
<a id="atom-d585794aab1f08dc"></a>🟦 2026-06-09 X·@cremieuxrecueil · approves BEMT for sunscreens · 监管政策
The FDA just approved BEMT for sunscreens!
tags: 好信源 · → daily
value: qty= · date=2026-06-10
📷 原图
<a id="atom-a60cff00348e8a7a"></a>🟦 2026-05-12 X·@zerohedge · CFO 离任 · 人事变动
TRUMP SAYS FDA CHIEF MARTY MAKARY IS MOVING ON
tags: 好信源 · → daily
value: date=2026-05-12
<a id="atom-4a0482f0d7077664"></a>🟦 2026-04-30 X·@AIStockSavvy · proposal open for public comment until June 29 2026 · 监管政策
Proposal open for public comment until June 29, 2026
tags: 好数字 · → daily
value: date=2026-06-29
<a id="atom-3b67b001db06bda2"></a>🟦 2026-04-15 X·@AIStockSavvy · 设置AdCom会议 · 监管政策
FDA sets up AdCom meeting to decide on lifting restrictions on certain peptides
tags: 好信源 · → daily
value: qty= · date=
<a id="atom-bea3998e4323b976"></a>🟦 2026-04-30 X·@AIStockSavvy · proposes removing semaglutide tirzepatide liraglutide from 503B compounding list · 监管政策
FDA proposes removing semaglutide, tirzepatide, liraglutide from 503B list
tags: 好信源 · → daily
<a id="atom-2705ffa9bf7021aa"></a>🟦 2026-04-30 X·@AIStockSavvy · finds no sufficient clinical need for bulk compounding of GLP-1 drugs · 监管政策
Agency finds no sufficient clinical need for bulk compounding
tags: 好信源 · → daily
<a id="atom-e81766992f2e3f53"></a>🟦 2026-04-15 X·@AIStockSavvy · 将12种肽从Category 2移除 · 监管政策
Now, after nominators withdrew 12 peptides, the FDA will remove them from Category 2
tags: 好数字 · → daily
value: qty=12 · date=2026-04-15
<a id="atom-f5d4e0c10a3a677f"></a>🟦 2026-04-15 X·@AIStockSavvy · 将在7月召开的PCAC会议上独立评估12种肽 · 监管政策
will bring them to PCAC at its next two meetings, beginning in July—where independent experts will rigorously evaluate each substance on its scientific merits
tags: 好数字 · → daily
<a id="atom-2b49e10a9b13cf4d"></a>🟦 2026-04-16 X·@AIStockSavvy · 信号鼓励睾丸素疗法新适应症 · 监管政策
FDA encourages new indication for testosterone therapy in low libido.
tags: 好信源 · → daily
value: qty=低性欲 · date=2026-04-16
<a id="atom-98c74d0db44e5e37"></a>🟦 2026-04-15 X·@AIStockSavvy · 行动将立即将需求从黑市转移 · 监管政策
will immediately begin shifting demand away from the black market
tags: 好观点 · → daily

🟥 多头 takes (bullish) (2)

<a id="atom-a4368ee7557de532"></a>🟥 2026-06-17 X·@AIStockSavvy · 对AMT-130的BLA路径反馈 · 监管政策
FDA's positive feedback on the BLA pathway for AMT-130 in Huntington's as a major positive
tags: 好信源 · → daily
value: direction=positive
📷 原图
<a id="atom-4791ae88f5b9bc2e"></a>🟥 2026-05-22 X·@MoodyWriter13 · 候选药物审批决策 · 监管政策
The FDA must be crazy not to approve their candidate for Huntington's disease
tags: 好观点 · → daily
value: date=next 1-2 years

🟥 空头 takes (bearish) (2)

<a id="atom-5133738a8088d4d1"></a>🟥 2026-06-30 X·@tbpn · 建议对多肽公司造成重大挫折 · 监管政策
The FDA’s recent recommendations on peptides are a *significant* setback for new and existing companies being built around the expectation that they will be able to sell compounded peptides.
tags: 好观点 · → daily
<a id="atom-e1553bbbe0ccb7ce"></a>🟥 2026-06-17 X·@MoodyWriter13 · 对AMT-130研究数据的不理性处理 · 监管政策
The old FDA, through its irrational handling of the AMT-130 study data from $QURE , essentially delegitimized the platform of $CLPT.
tags: 好观点 · → daily

🟥 中性 takes (neutral) (1)

<a id="atom-ecdb4e171aaadebb"></a>🟥 2026-05-30 X·@lu_sichu · need to do controlled trials · 监管政策
this is why we need the fda to do controlled trials
tags: 好观点 · → daily

🟦 新闻流 (squawk · 23)

展开新闻流 (FirstSquawk / financialjuice / wallstengine / DeItaone — 快讯, 非原创 take)

<a id="atom-867bbe813f2e93e5"></a>🟦 2026-06-23 X·@FirstSquawk · 考虑白宫助手担任领导职务 · 人事变动/监管政策
TRUMP ADMINISTRATION CONSIDERS A WHITE HOUSE AIDE FOR A TOP LEADERSHIP ROLE AT THE FDA.
tags: 好信源 · → daily
value: qty= · date=
<a id="atom-1da27a79d580d826"></a>🟦 2026-06-22 X·@FirstSquawk · regulatory reforms announced · 监管政策
FDA, NIH UNVEIL REGULATORY REFORMS TO BOOST U.S. DRUG RESEARCH AS MORE COMPANIES SHIFT STUDIES OVERSEAS.
tags: 好信源 · → daily
<a id="atom-336ce4bffc9a3bff"></a>🟦 2026-06-18 X·@FirstSquawk · 奶酪召回范围扩展至所有产品 · 监管政策/安全事故
FDA EXPANDS CLOVER HILL DAIRY CHEESE RECALL TO ALL PRODUCTS FOLLOWING 9 ILLNESSES, 8 HOSPITALIZATIONS AND 1 DEATH LINKED TO SOFT CHEESE PRODUCTS.
tags: 好信源 · → daily
value: direction=扩大
<a id="atom-8ccdd101a24c094f"></a>🟦 2026-06-04 X·@FirstSquawk · 开始审查堕胎药安全性 · 监管政策
FDA begins review of abortion pill safety as critics push for additional limits, according to WSJ
tags: 好信源 · → daily
value: qty= · date=
<a id="atom-5df88ac3d030b808"></a>🟦 2026-06-04 X·@FirstSquawk · mifepristone safety review timeline · 监管政策
FDA’s review of mifepristone safety is projected to last around six months, reports WSJ
tags: 好信源 · → daily
value: qty=six months · date=NA
<a id="atom-8afa3b48199d0f11"></a>🟦 2026-06-01 X·@FirstSquawk · 警告公众不使用非处方皮肤美白产品 · 监管政策
FDA: WARNS PUBLIC AGAINST USING NON-PRESCRIPTION SKIN BRIGHTENING PRODUCTS DUE TO ELEVATED LEVELS OF MERCURY AND/OR HYDROQUINONE
tags: 好信源 · → daily
value: qty=高汞和/或氢醌水平 · date=
<a id="atom-d4c7a2286446543d"></a>🟦 2026-06-01 X·@FirstSquawk · 已批准OTC皮肤亮白产品 · 监管政策
THERE ARE NO FDA-SANCTIONED OR LAWFULLY DISTRIBUTED OTC SKIN BRIGHTENING PRODUCTS
tags: 好信源 · → daily
value: qty=0 · date=2026-06-01
<a id="atom-29070ac09abbc23c"></a>🟦 2026-05-15 X·@FirstSquawk · 官员离职 · 人事变动
Controversial FDA official leaving drug center post in latest departure at agency-CBS
tags: 好信源 · → daily
<a id="atom-d660640e1aa27598"></a>🟦 2026-05-12 X·@DeItaone · Commissioner Makary 预期辞职 · 人事变动
FDA COMMISSIONER MAKARY EXPECTED TO RESIGN TUESDAY - SOURCES
tags: 好信源 · → daily
value: date=Tuesday
<a id="atom-4ab7b5c423b4e34f"></a>🟦 2026-05-08 X·@FirstSquawk ⭐ · Seventh Approval Under Priority Voucher Pilot Program · 监管政策
FDA Announces Seventh Approval Under Priority Voucher Pilot Program, Covering Bizengri
tags: 好数字·好信源 · → daily
value: qty=7th · date=2026-05-08
<a id="atom-9d0f754ecaa15851"></a>🟦 2026-05-08 X·@FirstSquawk · 批准 Zenocutuzumab-zbco · 产品发布/监管政策
FDA Greenlights Zenocutuzumab-zbco for Unresectable and Metastatic Cholangiocarcinoma
tags: 好信源 · → daily
<a id="atom-47819518bc8ca055"></a>🟦 2026-05-08 X·@FirstSquawk · commissioner 被计划解雇 · 人事变动
President Trump is said to have signed off on a plan to fire Dr. Marty Makary, the commissioner of the FDA, after clashes over policy-NYT
tags: 好信源 · → daily
value: date=2026-05-08 · direction=termination
<a id="atom-25a09059258f247c"></a>🟦 2026-05-06 X·@wallstengine · Micardis (telmisartan) 20 mg and 80 mg not withdrawn for safety or effectiveness reasons · 监管政策
FDA confirmed that Micardis (telmisartan) 20 mg and 80 mg was not withdrawn for safety or effectiveness reasons, clearing the way for generic approvals to continue.
tags: 好信源 · → daily
<a id="atom-f82fb46e661ab0aa"></a>🟦 2026-05-06 X·@FirstSquawk · 整合应用与提交数据来源系统门户于新平台HALO · 监管政策
The FDA said it has consolidated more than 40 application and submission data sources, systems, and portals across all centers into a new platform called HALO.
tags: 好信源 · → daily
value: qty=more than 40
<a id="atom-01cb5b7460334f55"></a>🟦 2026-05-06 X·@FirstSquawk · approval of first-of-its-kind drug for noise aversion and separation anxiety in dogs · 监管政策
The FDA said it has approved a first-of-its-kind drug for noise aversion and separation anxiety in dogs.
tags: 好数字 · → daily
<a id="atom-37d1fd87934ce10a"></a>🟦 2026-04-30 X·@wallstengine · 提议将司美格鲁肽、替尔泊肽和利拉鲁肽从503B散装清单中排除 · 监管政策
FDA proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B bulks list
tags: 好信源 · → daily
<a id="atom-80b4de1ef18d0bfa"></a>🟦 2026-04-30 X·@wallstengine · 声明称在已批准版本可用的情况下，没有临床需求让外包设施从散装物质中复方这些药物 · 监管政策
saying there is no clinical need for outsourcing facilities to compound them from bulk substances when approved versions are available
tags: 好信源 · → daily
<a id="atom-a966610a3fadba8d"></a>🟦 2026-04-30 X·@wallstengine · 征求意见截止日期为6月29日 · 监管政策
Public comments run through June 29
tags: 好信源 · → daily
value: date=June 29
<a id="atom-a5188d636bc66633"></a>🟦 2026-04-28 X·@FirstSquawk · leveraging AI to accelerate clinical trials · 监管政策
THE FDA LEVERAGES ARTIFICIAL INTELLIGENCE TO ACCELERATE CLINICAL TRIALS — WSJ.
tags: 好信源 · → daily
<a id="atom-a465d912a20d4070"></a>🟦 2026-04-28 X·@wallstengine · 计划今年夏天试点AI · 监管政策
The FDA plans to pilot AI this summer to pull clinical trial data directly from electronic health records and send it in real time to drugmakers and regulators.
tags: 好信源 · → daily
value: date=2026年夏天
📷 原图
<a id="atom-5e3bb39a051abb8e"></a>🟦 2026-04-28 X·@wallstengine · 试点AI目标 · 监管政策
The goal is to speed up trials, get drugs to patients faster, and boost U.S. biotech.
tags: 好信源 · → daily
📷 原图
<a id="atom-99323541f0da382c"></a>🟦 2026-04-27 X·@FirstSquawk · proposed pulling approval for · 监管政策
The FDA’s Center for Drug Evaluation and Research (CDER) has proposed pulling approval for Tavneos.
tags: 好信源 · → daily
value: qty=Tavneos
<a id="atom-cbdfea169ca1f08c"></a>🟦 2026-04-15 X·@wallstengine [老化中] · 将许多肽类从类别二移除 · 监管政策
RFK JR: FDA TO REMOVE MANY PEPTIDES FROM CATEGORY TWO
tags: 好信源 · → daily
value: qty=移除 · date=2026-04-15

⏱ 时间轴 (近 20)

🟦 2026-06-30 · fact · 建议不将7种多肽列入503A散装清单 · → daily
🟥 2026-06-30 · narrative · 建议对多肽公司造成重大挫折 · → daily
🟦 2026-06-29 · fact · 建议反对添加7种肽类药物至503A Bulk List · → daily
🟦 2026-06-25 · fact · 微泡批准状态 · → daily
🟦 2026-06-23 · fact · 考虑白宫助手担任领导职务 · → daily
🟦 2026-06-22 · fact · regulatory reforms announced · → daily
🟦 2026-06-18 · fact · 奶酪召回范围扩展至所有产品 · → daily
🟥 2026-06-17 · narrative · 对AMT-130的BLA路径反馈 · → daily
🟥 2026-06-17 · narrative · 对AMT-130研究数据的不理性处理 · → daily
🟦 2026-06-09 · fact · approves BEMT for sunscreens · → daily
🟦 2026-06-04 · fact · 领导层变动计划 · → daily
🟦 2026-06-04 · fact · 开始审查堕胎药安全性 · → daily
🟦 2026-06-04 · fact · mifepristone safety review timeline · → daily
🟦 2026-06-01 · fact · 警告公众不使用非处方皮肤美白产品 · → daily
🟦 2026-06-01 · fact · 已批准OTC皮肤亮白产品 · → daily
🟥 2026-05-30 · narrative · need to do controlled trials · → daily
🟥 2026-05-22 · narrative · 候选药物审批决策 · → daily
🟦 2026-05-19 · fact · 禁止女性参与临床试验年限 · → daily
🟦 2026-05-19 · fact · 禁止女性参与临床试验 · → daily
🟦 2026-05-15 · fact · 官员离职 · → daily

← 实体目录 · 系统日志

FDA